107 related articles for article (PubMed ID: 21587341)
1. European recommendations for the clinical use of HIV drug resistance testing: 2011 update.
Vandamme AM; Camacho RJ; Ceccherini-Silberstein F; de Luca A; Palmisano L; Paraskevis D; Paredes R; Poljak M; Schmit JC; Soriano V; Walter H; Sönnerborg A;
AIDS Rev; 2011; 13(2):77-108. PubMed ID: 21587341
[TBL] [Abstract][Full Text] [Related]
2. Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis.
Rhee SY; Blanco JL; Jordan MR; Taylor J; Lemey P; Varghese V; Hamers RL; Bertagnolio S; Rinke de Wit TF; Aghokeng AF; Albert J; Avi R; Avila-Rios S; Bessong PO; Brooks JI; Boucher CA; Brumme ZL; Busch MP; Bussmann H; Chaix ML; Chin BS; D'Aquin TT; De Gascun CF; Derache A; Descamps D; Deshpande AK; Djoko CF; Eshleman SH; Fleury H; Frange P; Fujisaki S; Harrigan PR; Hattori J; Holguin A; Hunt GM; Ichimura H; Kaleebu P; Katzenstein D; Kiertiburanakul S; Kim JH; Kim SS; Li Y; Lutsar I; Morris L; Ndembi N; Ng KP; Paranjape RS; Peeters M; Poljak M; Price MA; Ragonnet-Cronin ML; Reyes-Terán G; Rolland M; Sirivichayakul S; Smith DM; Soares MA; Soriano VV; Ssemwanga D; Stanojevic M; Stefani MA; Sugiura W; Sungkanuparph S; Tanuri A; Tee KK; Truong HM; van de Vijver DA; Vidal N; Yang C; Yang R; Yebra G; Ioannidis JP; Vandamme AM; Shafer RW
PLoS Med; 2015 Apr; 12(4):e1001810. PubMed ID: 25849352
[TBL] [Abstract][Full Text] [Related]
3. 2019 update of the drug resistance mutations in HIV-1.
Wensing AM; Calvez V; Ceccherini-Silberstein F; Charpentier C; Günthard HF; Paredes R; Shafer RW; Richman DD
Top Antivir Med; 2019 Sep; 27(3):111-121. PubMed ID: 31634862
[TBL] [Abstract][Full Text] [Related]
4. Consistency of drug-resistant mutations in plasma and peripheral blood mononuclear cells of patients with treatment-naïve and treatment-experienced HIV-1 infection.
Ma J; Chen Z; Fu C; Wei S; Liu J; Yang X; Chen X; Zhao Q; Sun Y; Huo Y
Front Cell Infect Microbiol; 2023; 13():1249837. PubMed ID: 38179423
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of HIV-1 drug resistance mutations in proviral DNA in the Swiss HIV Cohort Study, a retrospective study from 1995 to 2018.
Jaha B; Schenkel CD; Jörimann L; Huber M; Zaheri M; Neumann K; Leemann C; Calmy A; Cavassini M; Kouyos RD; Günthard HF; Metzner KJ;
J Antimicrob Chemother; 2023 Sep; 78(9):2323-2334. PubMed ID: 37545164
[TBL] [Abstract][Full Text] [Related]
6. Genotypic Resistance Testing of HIV-1 DNA in Peripheral Blood Mononuclear Cells.
Chu C; Armenia D; Walworth C; Santoro MM; Shafer RW
Clin Microbiol Rev; 2022 Dec; 35(4):e0005222. PubMed ID: 36102816
[TBL] [Abstract][Full Text] [Related]
7. A Tale of Three Recent Pandemics: Influenza, HIV and SARS-CoV-2.
Miranda MNS; Pingarilho M; Pimentel V; Torneri A; Seabra SG; Libin PJK; Abecasis AB
Front Microbiol; 2022; 13():889643. PubMed ID: 35722303
[TBL] [Abstract][Full Text] [Related]
8. Are We Ready for NGS HIV Drug Resistance Testing? The Second "Winnipeg Consensus" Symposium.
Ji H; Sandstrom P; Paredes R; Harrigan PR; Brumme CJ; Avila Rios S; Noguera-Julian M; Parkin N; Kantor R
Viruses; 2020 May; 12(6):. PubMed ID: 32471096
[TBL] [Abstract][Full Text] [Related]
9. External Quality Assessment Program for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Logistical Considerations.
Ji H; Parkin N; Gao F; Denny T; Jennings C; Sandstrom P; Kantor R
Viruses; 2020 May; 12(5):. PubMed ID: 32443529
[TBL] [Abstract][Full Text] [Related]
10. Clinical Outcomes Following the Use of Archived Proviral HIV-1 DNA Genotype to Guide Antiretroviral Therapy Adjustment.
Ellis KE; Nawas GT; Chan C; York L; Fisher J; Connick E; Zangeneh TT
Open Forum Infect Dis; 2020 Jan; 7(1):ofz533. PubMed ID: 31915714
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of Transmitted Drug Resistance Testing Before Initiation of Antiretroviral Therapy in HIV-Positive Individuals.
Lodi S; Günthard HF; Gill J; Phillips AN; Dunn D; Vu Q; Siemieniuk R; Garcia F; Logan R; Jose S; Bucher HC; Scherrer AU; Reiss P; van Sighem A; Boender TS; Porter K; Gilson R; Paraskevis D; Simeon M; Vourli G; Moreno S; Jarrin I; Sabin C; Hernán MA
J Acquir Immune Defic Syndr; 2019 Nov; 82(3):314-320. PubMed ID: 31609929
[TBL] [Abstract][Full Text] [Related]
12. Five rules for resistance management in the antibiotic apocalypse, a road map for integrated microbial management.
Raymond B
Evol Appl; 2019 Jun; 12(6):1079-1091. PubMed ID: 31297143
[TBL] [Abstract][Full Text] [Related]
13. HIV drug resistance among naïve HIV-infected patients in Iran.
Farrokhi M; Gholami M; Mohraz M; McFarland W; Baesi K; Abbasian L
J Res Med Sci; 2019; 24():31. PubMed ID: 31143232
[TBL] [Abstract][Full Text] [Related]
14. First evaluation of the Next-Generation Sequencing platform for the detection of HIV-1 drug resistance mutations in Belgium.
Dessilly G; Goeminne L; Vandenbroucke AT; Dufrasne FE; Martin A; Kabamba-Mukadi B
PLoS One; 2018; 13(12):e0209561. PubMed ID: 30596682
[TBL] [Abstract][Full Text] [Related]
15. Human Immunodeficiency Virus Drug Resistance: 2018 Recommendations of the International Antiviral Society-USA Panel.
Günthard HF; Calvez V; Paredes R; Pillay D; Shafer RW; Wensing AM; Jacobsen DM; Richman DD
Clin Infect Dis; 2019 Jan; 68(2):177-187. PubMed ID: 30052811
[TBL] [Abstract][Full Text] [Related]
16. Molecular Epidemiology of the HIV Epidemic in Three German Metropolitan Regions - Cologne/Bonn, Munich and Hannover, 1999-2016.
Stecher M; Chaillon A; Eberle J; Behrens GMN; Eis-Hübinger AM; Lehmann C; Jablonka A; Bogner J; Fätkenheuer G; Spinner CD; Wasmuth JC; Kaiser R; Mehta SR; Vehreschild JJ; Hoenigl M
Sci Rep; 2018 May; 8(1):6799. PubMed ID: 29717148
[TBL] [Abstract][Full Text] [Related]
17. Decoding HIV resistance: from genotype to therapy.
Weber IT; Harrison RW
Future Med Chem; 2017 Sep; 9(13):1529-1538. PubMed ID: 28791894
[TBL] [Abstract][Full Text] [Related]
18. Collaborative update of a rule-based expert system for HIV-1 genotypic resistance test interpretation.
Paredes R; Tzou PL; van Zyl G; Barrow G; Camacho R; Carmona S; Grant PM; Gupta RK; Hamers RL; Harrigan PR; Jordan MR; Kantor R; Katzenstein DA; Kuritzkes DR; Maldarelli F; Otelea D; Wallis CL; Schapiro JM; Shafer RW
PLoS One; 2017; 12(7):e0181357. PubMed ID: 28753637
[TBL] [Abstract][Full Text] [Related]
19. Agreement between an in-house replication competent and a reference replication defective recombinant virus assay for measuring phenotypic resistance to HIV-1 protease, reverse transcriptase, and integrase inhibitors.
Saladini F; Giannini A; Boccuto A; Vicenti I; Zazzi M
J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28303602
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Transmitted Drug-Resistance Mutations and Polymorphisms in HIV-1 Reverse Transcriptase, Protease, and gp41 Sequences Among Recent Seroconverters in Southern Poland.
Smoleń-Dzirba J; Rosińska M; Kruszyński P; Bratosiewicz-Wąsik J; Wojtyczka R; Janiec J; Szetela B; Beniowski M; Bociąga-Jasik M; Jabłonowska E; Wąsik TJ; The Cascade Collaboration In EuroCoord A
Med Sci Monit; 2017 Feb; 23():682-694. PubMed ID: 28167814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
